What is the CVR number of PlasmoClean ApS?

PlasmoClean ApS is registered with CVR / Virk under CVR 43977261.

What is the revenue of PlasmoClean ApS?

PlasmoClean ApS reported revenue of DKK -9K in 2024.

Who is the CEO of PlasmoClean ApS?

Michael Lexner is Chief Executive Officer of PlasmoClean ApS, in role since 2024.

Where is PlasmoClean ApS headquartered?

PlasmoClean ApS's registered address is Strandvejen 100.

PlasmoClean ApS

APSActive

CVR 43977261Strandvejen 100Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2023— employeesplasmoclean.dk

Full Risika report

Revenue 2024

DKK -9K

+278% vs 2023

EBITDA margin

100.0%

-278% vs 2023

Equity ratio

100.0%

Financial strength

Net profit 2024

DKK -11K

-355% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -9K	+278%
EBITDA	DKK -9K	-278%
Net profit	DKK -11K	-355%
Total assets	DKK 26K	-30%
Equity	DKK 26K	-30%
Employees	—	—

Item	2023	2024
Revenue	-2	-9
Staff expenses	-0	-0
EBITDA	-2	-9
Depreciation & amort.	-0	-0
EBIT	-2	-9
Net financials	0	-2
Profit before tax	-2	-11
Tax	-0	-0
Net profit	-2	-11

Item	2023	2024
Total assets	38	26
Equity	38	26
Long-term debt	0	0
Short-term debt	0	0
Total debt	0	0

Name	Role	Member since	Age	Other directorships
ML Michael Lexner Chief Executive Officer	Chief Executive Officer	2024	—	—
BD Brian Drongesen Schmidt Chief Executive Officer	Chief Executive Officer	2024	—	—
PJ Preben Joffe Management	Management	2023	—	—
PA Peter Andreas Stakemann Management	Management	2023	—	—

Shareholder	Type	Ownership	Votes	Since
JOFFE CONSULT ApS	Company	66.7%	66.7%	2024
HOLDINGSELSKABET 20.10.2010 ApS	Company	20.0%	20.0%	2024
VABB Holdings ApS	Company	33.3%	33.3%	2024
MJ HOLDING AF 1/9 2009 ApS	Company	33.3%	33.3%	2024

Person	Role here	Other companies
Michael Lexner	Chief Executive Officer	0 companies
Brian Drongesen Schmidt	Chief Executive Officer	0 companies
Preben Joffe	Management	0 companies
Peter Andreas Stakemann	Management	0 companies

PlasmoClean ApS

APSActive

CVR 43977261Strandvejen 100Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2023— employeesplasmoclean.dk

Full Risika report

Revenue 2024

DKK -9K

+278% vs 2023

EBITDA margin

100.0%

-278% vs 2023

Equity ratio

100.0%

Financial strength

Net profit 2024

DKK -11K

-355% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -9K	+278%
EBITDA	DKK -9K	-278%
Net profit	DKK -11K	-355%
Total assets	DKK 26K	-30%
Equity	DKK 26K	-30%
Employees	—	—